Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Belldegrun Arie (CIK 1296549) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-09-16). Recent activity: Buy LBRX (547,648 shares), Buy LBRX (1,262 shares), Buy LBRX (332,566 shares), Buy LBRX (767 shares), Sell KRON (2.8M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-16 | LB PHARMACEUTICALS INC (LBRX) | 10% Owner | Buy | 547,648 | $0 |
| 2025-09-16 | LB PHARMACEUTICALS INC (LBRX) | 10% Owner | Buy | 1,262 | $0 |
| 2025-09-16 | LB PHARMACEUTICALS INC (LBRX) | 10% Owner | Buy | 332,566 | $5.0M |
| 2025-09-16 | LB PHARMACEUTICALS INC (LBRX) | 10% Owner | Buy | 767 | $11,505 |
| 2025-06-20 | Kronos Bio, Inc. (KRON) | Director | Sell | 2.8M | $1.6M |
| 2025-06-20 | Kronos Bio, Inc. (KRON) | Director | Sell | 679,575 | $387,358 |
Source: SEC Form 4 filings · as of 2025-09-16